Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene W Gerner

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Expert Review of Gastroenterology & Hepatology|August 30, 2012
Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancerNathaniel S Rial, Jason A Zell, Alfred M Cohen, et al.
Molecular Carcinogenesis|January 8, 2008
Activated K-RAS increases polyamine uptake in human colon cancer cells through modulation of caveolar endocytosisUpal K Basu Roy, Nathaniel S Rial, Karen L Kachel, et al.
Molecular Carcinogenesis|January 30, 2004
Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cellsNatalia A Ignatenko, Naveen Babbar, Dipti Mehta, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 15, 2017
Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse ModelSwati Chandra, Ariel C Nymeyer, Photini Faith Rice, et al.
Cancer Biology & Therapy|October 9, 2007
Activation of polyamine catabolism by N1, N11-diethylnorspermine alters the cellular localization of mTOR and downregulates mTOR protein level in glioblastoma cellsRongcai Jiang, Woonyoung Choi, Limei Hu, et al.
Nutrition and Cancer|September 11, 2014
Dietary polyamine intake and polyamines measured in urineAshley J Vargas, Erin L Ashbeck, Cynthia A Thomson, et al.
International Journal of Cancer|January 29, 2009
Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancerNathaniel S Rial, Gwendal Lazennec, Anil R Prasad, et al.
Cancer Biology & Therapy|November 15, 2002
Selenomethionine inhibits growth and suppresses cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell linesAntonio Baines, Michele Taylor-Parker, Anne-Christine Goulet, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 26, 2009
Components of metabolic syndrome and metachronous colorectal neoplasiaErin L Ashbeck, Elizabeth T Jacobs, María Elena Martínez, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2009
Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomasJason A Zell, Daniel Pelot, Wen-Pin Chen, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Expert Review of Gastroenterology & Hepatology|August 30, 2012
Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancerNathaniel S Rial, Jason A Zell, Alfred M Cohen, et al.
Molecular Carcinogenesis|January 8, 2008
Activated K-RAS increases polyamine uptake in human colon cancer cells through modulation of caveolar endocytosisUpal K Basu Roy, Nathaniel S Rial, Karen L Kachel, et al.
Molecular Carcinogenesis|January 30, 2004
Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cellsNatalia A Ignatenko, Naveen Babbar, Dipti Mehta, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 15, 2017
Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse ModelSwati Chandra, Ariel C Nymeyer, Photini Faith Rice, et al.
Cancer Biology & Therapy|October 9, 2007
Activation of polyamine catabolism by N1, N11-diethylnorspermine alters the cellular localization of mTOR and downregulates mTOR protein level in glioblastoma cellsRongcai Jiang, Woonyoung Choi, Limei Hu, et al.
Nutrition and Cancer|September 11, 2014
Dietary polyamine intake and polyamines measured in urineAshley J Vargas, Erin L Ashbeck, Cynthia A Thomson, et al.
International Journal of Cancer|January 29, 2009
Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancerNathaniel S Rial, Gwendal Lazennec, Anil R Prasad, et al.
Cancer Biology & Therapy|November 15, 2002
Selenomethionine inhibits growth and suppresses cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell linesAntonio Baines, Michele Taylor-Parker, Anne-Christine Goulet, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 26, 2009
Components of metabolic syndrome and metachronous colorectal neoplasiaErin L Ashbeck, Elizabeth T Jacobs, María Elena Martínez, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2009
Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomasJason A Zell, Daniel Pelot, Wen-Pin Chen, et al.
Pageof 9